Loeb & Loeb LLP is pleased to announce that James N. Czaban has joined the firm’s Washington, DC office as a partner in the FDA Regulatory & Compliance Department. His practice focuses on advising clients on complex regulatory strategies and compliance matters in the pharmaceutical, biotechnology, food, medical device, and Life Sciences industries.
“Jim is an important and strategic addition to our growing team,” said Scott Liebman, Chair of Loeb’s FDA Regulatory & Compliance Department and a co-chair of its Life Sciences practice. “He has an impressive track record and reputation for helping clients navigate complex legal, regulatory and policy issues in the life sciences industry. We could not be more pleased that he is joining us.”
Jim provides strategic, business-oriented regulatory guidance to companies at all stages of a product’s lifecycle, and represents clients in proceedings with federal and state government agencies, including the Food and Drug Administration, the Federal Trade Commission, the Drug Enforcement Administration, the Office of the Inspector General of the Department of Health and Human Services, and the Department of Justice. He also represents private equity, bank, and venture capital clients, and other entities involved with life sciences, counseling these clients with respect to regulatory due diligence and deal strategies in connection with financings, public offerings, mergers and acquisitions, licensing and joint venture agreements.
“I’m thrilled to join a firm with such a strategic, collaborative focus in the life sciences and to be part of such a client-centric team of professionals,” said Jim. “Loeb has clearly defined itself as a leader in this area, and is poised for even greater success. It’s an exciting time to come on board."
“We are thrilled to welcome Jim to the DC office,” said Richard Lorenzo, Office Administrative Partner for Washington, DC. “His reputation and decades of industry experience significantly expands and diversifies the services we can offer clients.”
Jim earned his J.D. from the University of Virginia School of Law and his B.A. from the University of California at Berkeley. He has been recognized as a leading FDA practitioner by numerous independent ratings guides, including Chambers USA, Who’s Who Legal Life Sciences, Best Lawyers in America, LMG Life Sciences, Super Lawyers, and Lawdragon’s 3,000 Leading Lawyers. He has twice won the Burton Award for Distinguished Legal Writing. He was previously with DLA Piper as partner and chair of their FDA group and is the second lateral partner to join Loeb’s growing DC office in the past month.